POCT CRP control
Human blood / serum matrix
For C-reactive protein measurement on point-of-care analysers, at levels spanning the clinical decision range.
Ready to use, no reconstitution step.
Point-of-care testing controls
Reliable POCT withquality controlyou can defend.
Verilox manufactures bulk control materials for point-of-care testing devices. Human matrix, ready to use, and verified lot by lot for stability and homogeneity, built for IVD manufacturers and supply chains worldwide.
- 12 weeks
- Recommended shelf life, blood-based controls
- < 20%
- Expected change after one week at 37 °C
- ISO 13528
- Homogeneity testing on every production lot
Why controls matter
The rise of POCT: convenience needs a reference point.
Point-of-care testing has grown quickly because it produces results at the patient's side. Clinicians can act immediately, and outcomes improve when a decision no longer waits on a central laboratory.
That advantage only holds if the result is right. A POCT device is only as trustworthy as the data it generates, which is why routine quality control belongs in every point-of-care workflow, and why control material has to behave like a real sample.
Verilox produces tailored bulk controls: a cost-effective, consistent supply for IVD manufacturers who ship devices and control material together.
How POCT and its quality control work →Product families
Two blood-based control lines, supplied in bulk.
POCT glucose control
Human blood matrix
For glucose measurement on point-of-care meters and analysers, covering low, normal and elevated decision levels.
Ready to use, no reconstitution step.
Performance
Every claim is tied to a test we run on the lot.
Commutability, stability, homogeneity and lot-to-lot consistency are checked before release.
High commutability
Human serum and blood matrix, so the control behaves on the device the way a patient sample does.
Verified stability
Recommended shelf life of 12 weeks for blood-based POCT CRP and POCT glucose controls, with triplicate measurement at every time point.
Accelerated stability
Each production lot is incubated one week at 37 °C and compared with reference material stored at +2 to 8 °C; a change below 20% is expected.
Vial-to-vial homogeneity
Random vials from every lot are tested to ISO 13528 and released against the total allowable error limits for CRP and glucose defined in the Rilibäk guideline.
Minimal lot-to-lot variation
Consistent target values are maintained across production lots, so results stay familiar from one delivery to the next.
Clinically relevant levels
Levels are set across the assay range and around the values that matter for clinical decision making.
Tailor-made
Specified to your device, not to a catalogue.
We adjust the control to the assay it has to verify, and leave out what you do not need.
- Different filling volumes
- Adjustable target values and levels
- Single or multi-analyte combinations
- Consistent target values across repeat lots
Who we are
A manufacturer, not a reseller.
Verilox is the point-of-care quality control line of JTC Diagnosemittel GmbH, produced in Vöhl, Germany.
Scientific accuracy
Every specification is tied to a measurement we perform ourselves.
Regulatory alignment
Documentation and release criteria written for IVD manufacturers.
Long-term performance
Consistent target values from one production lot to the next.
Ready to drive the future of IVD technologies?
A long-term commitment to science, quality and manufacturing consistency, trusted by partners across the globe.
Contact us